Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,709 public trials 1,044 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

NCT03517488

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
Locations
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • UCLA Hematology-Oncology Clinic (Westwood) Los Angeles, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
View all 17 locations
View Trial Details
Completed

A Study of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin) in Participants With Solid Tumors

NCT03386942

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Eisai Trial Site 5 Matsuyama, Ehime, Japan
  • Eisai Trial Site 6 Kurume, Fukuoka, Japan
  • Eisai Trial Site 8 Sapporo, Hokkaido, Japan
  • Eisai Trial Site 4 Akashi, Hyōgo, Japan
View Trial Details
Completed

A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

NCT02857270

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +30 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
View all 13 locations
View Trial Details
Completed

Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea

NCT03271554

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Inje University Busan Paik Hospital Busan, South Korea
  • Dong-A University Hospital Busan, South Korea
  • Pusan National University Hospital Busan, South Korea
  • Kosin University Gospel Hospital Busan, South Korea
View all 37 locations
View Trial Details

Related conditions